What are the latest funding news in the mental health market? (June 2026)
Download our beautiful pitch about the mental health market
In our mental health market deck, you will find everything you need to understand the market
Between January 2026 and June 8, 2026, the mental health market saw funding concentrate around psychiatry access, clinical workflow tools, neuromodulation, and FDA-cleared digital treatments.
The largest rounds went to companies that either deliver care directly or make clinical mental health infrastructure easier to scale through payers, providers, and employers.
AI appeared across several rounds, but the strongest companies positioned it as supervised clinical infrastructure rather than as standalone wellness content.
And if you want to better understand this new industry, you can download our pitch covering the mental health market.
Insights
- The 12 disclosed rounds represented about $648.7M, and more than 55% of that capital went to virtual psychiatry and therapy networks.
- Psychiatry-heavy models raised the largest checks, with Talkiatry, Grow Therapy, Salma Health, and Blossom Health together showing investor appetite for formal clinical care delivery.
- Interventional psychiatry moved from niche to fundable infrastructure, with Salma Health and Ampa both raising around TMS, neuromodulation, and treatment-resistant depression.
- AI was most credible when attached to licensed clinicians, as Jimini Health, Blossom Health, Tava Health, and Oasys Health all framed AI as clinical support, not a replacement.
- The mental health market still favored U.S.-centric reimbursement models, with most companies targeting employers, health plans, Medicaid, Medicare, or provider organizations.
- FDA-cleared digital therapeutics stayed relevant, but Big Health's round suggests reimbursement readiness is now as important as clinical validation.
- Substance-use exposure was present but indirect, mainly through psychiatry platforms and neuropsychiatric drug development rather than pure addiction treatment startups.
- The strongest infrastructure theme was workflow relief for clinicians, including documentation, referrals, billing, care coordination, and between-session patient support.
- Early-stage rounds were still large, with Salma Health's $80M Series A and Gilgamesh Pharma's $60M Series A showing strong demand for hard clinical models.
As this chart shows, and as featured in our mental health market deck, search interest in men’s mental health has been rising steadily
Summary table of the latest funding deals in the mental health market as of June 2026
We define the mental health market as the set of services and products that diagnose, treat, or clinically manage mental and substance use disorders.
We include licensed providers, facilities, medications, and clinically validated digital tools that are used to assess or treat recognized mental and substance use conditions.
We exclude general wellness, self-help, fitness, and lifestyle products that aim to improve mood or wellbeing but are not used as formal clinical treatment.
You can also read our detailed analysis to understand how funding activity in the mental health market has evolved over the last few years.
We also have a quarter-by-quarter analysis of funding activity in the market here.
Finally, you can check our complete list of fundraising deals for the mental health market (we update this list every quarter) as well as our ranking of the most funded startups.
| Name | When | Amount in $ | Round Type | Category |
|---|---|---|---|---|
| Ampa | May 2026 | ~$17.0M | Oversubscribed financing | Interventional psychiatry & neuromodulation device |
| Tava Health | April 21, 2026 | $40.0M | Series C | Therapy access & behavioral health benefits |
| Trayt Health | April 15 to 17, 2026 | $7.17M | Private funding | Behavioral health care coordination |
| Jimini Health | March 31 to April 2, 2026 | $17.0M | Seed | Clinician-supervised mental health AI |
| Blossom Health | March 26, 2026 | $20.0M | Seed & Series A | Telepsychiatry & psychiatry operating system |
| Gilgamesh Pharma | March 24, 2026 | $60.0M | Series A | Neuropsychiatric medicines |
| Grow Therapy | March 3, 2026 | $150.0M | Series D | Provider network & therapist enablement |
| Salma Health | March 3, 2026 | $80.0M | Series A | Interventional psychiatry clinics |
| Talkiatry | February 12, 2026 | $210.0M | Series D | Virtual psychiatry provider |
| Big Health | February 12, 2026 | $23.7M | Strategic funding | FDA-cleared digital therapeutics |
| Somethings | February 10, 2026 | $19.2M | Series A | Youth behavioral health support |
| Oasys Health | January 8, 2026 | $4.6M | Seed & pre-seed | Behavioral health operating system & clinical workflow |
All the latest funding deals during in the mental health market as of June 2026
Ampa raised about $17M in May 2026 to scale portable TMS for depression treatment.
When was it?
Ampa announced the financing in May 2026, with the news release published in mid-May.
Who are they?
Ampa makes Ampa One, an FDA-cleared portable TMS system that helps clinics deliver depression treatment in a simpler format.
Geographical focus?
Ampa is mainly focused on the United States, with clinic use across more than 30 states and early international expansion through Israel approval.
Why do we include them in the mental health market?
Ampa belongs in the mental health market because TMS is a formal clinical treatment for depression, under interventional psychiatry and neuromodulation devices.
What is the company stage?
Ampa is in early commercial growth, with FDA clearance, active clinic deployment, and a rollout plan beyond its initial U.S. footprint.
How much did they raise?
Ampa's latest disclosed financing was reported at about $17.0M, although the company did not confirm the exact round size in its release.
What round is it?
Ampa described the round as an oversubscribed financing, without giving a formal Series A, B, or C label.
Why did they raise?
Ampa raised to accelerate rollout of Ampa One, meet clinic demand, and prepare for broader international availability.
Tava Health raised $40M in April 2026 to expand its behavioral health platform.
When was it?
Tava Health announced the Series C on April 21, 2026, with additional coverage published on April 23.
Who are they?
Tava Health connects people to licensed therapists through employers, health plans, and provider partnerships, while giving clinicians practice tools.
Geographical focus?
Tava Health is focused on the United States and says its network reaches all 50 states through integrations with more than 200 health plans.
Why do we include them in the mental health market?
Tava Health belongs in the mental health market because Tava Health provides access to licensed therapy and behavioral health care infrastructure.
What is the company stage?
Tava Health is in growth stage, with thousands of providers, payer distribution, employer relationships, and strong reported revenue growth.
How much did they raise?
Tava Health raised $40.0M in this round.
What round is it?
Tava Health raised a Series C round led by Centana Growth Partners.
Why did they raise?
Tava Health raised to launch and scale TavaCare, Symphony by Tava Health, and Tava Guide across employers, clinicians, and health plans.
This chart, featured in our mental health market deck, compares the main business model options for tele-mental health platforms
Trayt Health raised $7.17M in April 2026 for behavioral health coordination.
When was it?
Trayt Health filed the financing on April 15, 2026, and the round was covered on April 16 and April 17.
Who are they?
Trayt Health provides a behavioral health coordination platform for screening, referrals, care tracking, and program management.
Geographical focus?
Trayt Health is focused on the United States and expanded to Arizona in April 2026, reaching its ninth state and 20th behavioral health program.
Why do we include them in the mental health market?
Trayt Health belongs in the mental health market because Trayt Health supports clinical behavioral health coordination across providers, managed care, and state programs.
What is the company stage?
Trayt Health is in early growth, with multi-state program adoption but still a relatively small private financing profile.
How much did they raise?
Trayt Health raised $7.17M in the disclosed private round.
What round is it?
Trayt Health's round was a private financing, with no formal series label disclosed.
Why did they raise?
Trayt Health raised to expand its integrated behavioral health coordination platform into more states and programs.
Jimini Health raised $17M in spring 2026 to expand supervised behavioral health AI.
When was it?
Jimini Health's round was reported on March 31, 2026, with follow-on coverage on April 2, 2026.
Who are they?
Jimini Health builds Sage, a clinically supervised AI behavioral health assistant that supports patients between therapy sessions.
Geographical focus?
Jimini Health is focused on the United States and sells into behavioral health provider organizations.
Why do we include them in the mental health market?
Jimini Health belongs in the mental health market because Jimini Health's AI is embedded in supervised therapy workflows rather than general self-help.
What is the company stage?
Jimini Health is seed-stage, with early provider adoption and more than $25M in total funding after this round.
How much did they raise?
Jimini Health raised $17.0M in this round.
What round is it?
Jimini Health raised a Seed round.
Why did they raise?
Jimini Health raised to invest in AI technology, support more care settings, and expand into national behavioral health providers.
This chart, featured in our mental health market deck, shows why Talkspace is winning in mental health
Blossom Health raised $20M in March 2026 for AI-powered telepsychiatry.
When was it?
Blossom Health announced the combined Seed and Series A funding on March 26, 2026.
Who are they?
Blossom Health is a telepsychiatry platform that pairs human psychiatrists with AI copilots for clinical and administrative work.
Geographical focus?
Blossom Health is focused on the United States and operated in nine states when the funding was announced.
Why do we include them in the mental health market?
Blossom Health belongs in the mental health market because Blossom Health delivers licensed psychiatric care through psychiatrists.
What is the company stage?
Blossom Health is in early growth, with stealth launch history, state expansion plans, and payer contract ambitions.
How much did they raise?
Blossom Health raised $20.0M in combined Seed and Series A funding.
What round is it?
Blossom Health's financing combined Seed and Series A funding.
Why did they raise?
Blossom Health raised to expand to more states, add payer contracts, improve AI copilot features, and increase R&D.
Gilgamesh Pharma raised $60M in March 2026 for neuropsychiatric therapies.
When was it?
Gilgamesh Pharma announced the Series A on March 24, 2026.
Who are they?
Gilgamesh Pharma develops next-generation neuropsychiatric medicines for psychiatric and neurological disorders.
Geographical focus?
Gilgamesh Pharma is based in New York and develops medicines for global therapeutic markets.
Why do we include them in the mental health market?
Gilgamesh Pharma belongs in the mental health market because Gilgamesh Pharma develops drug candidates for psychiatric and substance-use conditions.
What is the company stage?
Gilgamesh Pharma is a clinical-stage, pre-commercial biotech with clinical and preclinical neuropsychiatric assets.
How much did they raise?
Gilgamesh Pharma raised $60.0M in this round.
What round is it?
Gilgamesh Pharma raised an oversubscribed Series A round.
Why did they raise?
Gilgamesh Pharma raised to advance its clinical and preclinical neuropsychiatric pipeline after its AbbVie-related spinout.
In our mental health market deck, we identify pain points entrepreneurs should prioritize
Grow Therapy raised $150M in March 2026 at a reported $3B valuation.
When was it?
Grow Therapy announced the Series D on March 3, 2026.
Who are they?
Grow Therapy connects patients to therapists and psychiatric providers while helping providers take insurance and run their practices.
Geographical focus?
Grow Therapy is focused on the United States and works with health plans, employers, health systems, Medicaid, Medicare, and independent providers.
Why do we include them in the mental health market?
Grow Therapy belongs in the mental health market because Grow Therapy enables insured therapy and psychiatric care through a provider network.
What is the company stage?
Grow Therapy is in growth stage, with millions of visits enabled, more than 125 health plan deals, and broad U.S. coverage.
How much did they raise?
Grow Therapy raised $150.0M in this round.
What round is it?
Grow Therapy raised a Series D round led by TCV and Growth Equity at Goldman Sachs Alternatives.
Why did they raise?
Grow Therapy raised to deepen employer and health system partnerships and expand its scaled mental health provider network.
Salma Health raised $80M in March 2026 for interventional psychiatry clinics.
When was it?
Salma Health announced the Series A on March 3, 2026.
Who are they?
Salma Health builds brain-health clinics combining diagnostics, psychiatry, psychotherapy, TMS, neuromodulation, counseling, and medication management.
Geographical focus?
Salma Health is focused on the United States, starting with California locations in Berkeley, Fremont, Orange County, and San Diego.
Why do we include them in the mental health market?
Salma Health belongs in the mental health market because Salma Health provides clinical psychiatric treatments, including TMS and neuromodulation.
What is the company stage?
Salma Health is in early growth, having emerged from stealth with clinic locations and a major Series A for expansion.
How much did they raise?
Salma Health raised $80.0M in this round.
What round is it?
Salma Health raised a Series A round led by Mubadala Capital and ARCH Venture Partners.
Why did they raise?
Salma Health raised to build integrated brain-health centers and generate outcomes data for interventional psychiatry.
This market map, featured in our mental health market deck, highlights top companies and startups in the mental health market
Talkiatry raised $210M in February 2026 to scale virtual psychiatry.
When was it?
Talkiatry announced the Series D on February 12, 2026.
Who are they?
Talkiatry is a virtual psychiatry provider that employs psychiatrists and treats mental health and substance-use conditions.
Geographical focus?
Talkiatry is focused on the United States and is in-network with more than 100 insurers nationwide.
Why do we include them in the mental health market?
Talkiatry belongs in the mental health market because Talkiatry directly delivers licensed psychiatric care and therapy for recognized conditions.
What is the company stage?
Talkiatry is in late-stage growth, with more than 800 full-time psychiatrists and more than $400M raised in total.
How much did they raise?
Talkiatry raised $210.0M in this round.
What round is it?
Talkiatry raised a Series D round led by Perceptive Advisors.
Why did they raise?
Talkiatry raised to enhance technology, scale its virtual psychiatry reach, and build AI-enabled operations.
Big Health raised $23.7M in February 2026 for FDA-cleared digital treatments.
When was it?
Big Health announced the strategic funding round on February 12, 2026.
Who are they?
Big Health develops FDA-cleared digital mental health treatments, including SleepioRx for insomnia disorder and DaylightRx for generalized anxiety disorder.
Geographical focus?
Big Health is focused on U.S. commercialization and reimbursement for digital mental health treatments.
Why do we include them in the mental health market?
Big Health belongs in the mental health market because Big Health provides FDA-cleared and reimbursable treatments for recognized mental health conditions.
What is the company stage?
Big Health is in commercialization and growth stage, with FDA-cleared products and provider adoption underway.
How much did they raise?
Big Health raised $23.7M in this round.
What round is it?
Big Health raised a strategic funding round co-led by .406 Ventures and AlleyCorp.
Why did they raise?
Big Health raised to accelerate adoption of reimbursable FDA-cleared digital mental health treatments through provider partnerships.
This chart, featured in our mental health market deck, illustrates yearly funding for mental health startups
Somethings raised $19.2M in February 2026 for youth mental health peer support.
When was it?
Somethings announced the Series A on February 10, 2026, with additional coverage on February 11.
Who are they?
Somethings connects teens and young adults with trained Certified Peer Specialist mentors, with AI used to support mentors.
Geographical focus?
Somethings is focused on the United States and partners with Medicaid programs, schools, state governments, and care organizations.
Why do we include them in the mental health market?
Somethings belongs in the mental health market because Somethings provides behavioral health support with safety screening, clinical oversight, and escalation pathways.
What is the company stage?
Somethings is in Series A and early growth, with early funding history and institutional partnerships becoming the key scale channel.
How much did they raise?
Somethings raised $19.2M in this round.
What round is it?
Somethings raised a Series A round led by Catalio Capital.
Why did they raise?
Somethings raised to expand Medicaid, school, state, and healthcare partnerships while improving mentor training and clinical oversight.
Oasys Health raised $4.6M in January 2026 for a behavioral health operating system.
When was it?
Oasys Health announced the funding on January 8, 2026.
Who are they?
Oasys Health builds an AI-native operating system for behavioral health clinics, covering documentation, scheduling, billing, decision support, and outcomes tracking.
Geographical focus?
Oasys Health is focused on the United States and targets mental health clinics, behavioral health centers, MSOs, universities, and schools.
Why do we include them in the mental health market?
Oasys Health belongs in the mental health market because Oasys Health is infrastructure for clinical behavioral health delivery and outcomes management.
What is the company stage?
Oasys Health is seed-stage, with early clinic traction and plans to scale into more enterprise behavioral health organizations.
How much did they raise?
Oasys Health raised $4.6M total, including a $4.0M seed and a $0.6M pre-seed.
What round is it?
Oasys Health raised Seed and pre-seed funding.
Why did they raise?
Oasys Health raised to improve its AI platform, deepen integrations, grow the technical team, and expand clinic partnerships.
Related blog posts
- How strong is fundraising in the mental health market right now?
- The most important recent news in the mental health market
- How big is the mental health market really?
- The evolution of funding activity in the mental health market
- The main fundraising trends in the mental health market
- An overview of all funding deals in the mental health market
- The startups that have raised the most funding in the mental health market
- The most highly valued startups in the mental health market
- The full range of business models in the mental health market
